|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shibata T and Aburatani H: Exploration of
liver cancer genomes. Nat Rev Gastroenterol Hepatol. 11:340–349.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pogribny IP and Rusyn I: Role of
epigenetic aberrations in the development and progression of human
hepatocellular carcinoma. Cancer Lett. 342:223–230. 2014.
View Article : Google Scholar :
|
|
6
|
You JS and Jones PA: Cancer genetics and
epigenetics: Two sides of the same coin? Cancer Cell. 22:9–20.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Um TH, Kim H, Oh BK, Kim MS, Kim KS, Jung
G and Park YN: Aberrant CpG island hypermethylation in dysplastic
nodules and early HCC of hepatitis B virus-related human multistep
hepato-carcinogenesis. J Hepatol. 54:939–947. 2011. View Article : Google Scholar
|
|
8
|
Raggi C and Invernizzi P: Methylation and
liver cancer. Clin Res Hepatol Gastroenterol. 37:564–571. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mikeska T, Bock C, Do H and Dobrovic A:
DNA methylation biomarkers in cancer: Progress towards clinical
implementation. Expert Rev Mol Diagn. 12:473–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sceusi EL, Loose DS and Wray CJ: Clinical
implications of DNA methylation in hepatocellular carcinoma. HPB
Oxf. 13:369–376. 2011. View Article : Google Scholar
|
|
11
|
Napolitano LM and Meroni G: TRIM family:
Pleiotropy and diversification through homomultimer and
heteromultimer formation. IUBMB Life. 64:64–71. 2012. View Article : Google Scholar
|
|
12
|
Thom CS, Traxler EA, Khandros E, Nickas
JM, Zhou OY, Lazarus JE, Silva AP, Prabhu D, Yao Y, Aribeana C, et
al: Trim58 degrades Dynein and regulates terminal erythropoiesis.
Dev Cell. 30:688–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao R, Li J, Xin J, Wu J, Guo J, Zhang L,
Jiang L, Zhang W, Yang Z and Li L: Methylation profile of single
hepatocytes derived from hepatitis B virus-related hepatocellular
carcinoma. PLoS One. 6:e198622011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu X, Hu B, Huang Y, Deng Y, Wang X and
Zheng F: Hypermethylation of ACP1, BMP4, and TSPYL5 in
hepato-cellular carcinoma and their potential clinical
significance. Dig Dis Sci. 61:149–157. 2016. View Article : Google Scholar
|
|
15
|
Zhang X, Liu S, Shen C, Wu Y, Zhang L,
Chen X and Lu F: DNA methylation consistency implicates the primary
tumor cell origin of recurrent hepatocellular carcinoma.
Epigenomics. 7:581–592. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Cheng J, Xu C, Liu S, Jiang S, Xu
Q, Chen X, Zhuang H and Lu F: Quantitative methylation analysis
reveals gender and age differences in p16INK4a hypermethylation in
hepatitis B virus-related hepatocellular carcinoma. Liver Int.
32:420–428. 2012.
|
|
17
|
Zhang X, Wang J, Cheng J, Ding S, Li M,
Sun S, Zhang L, Liu S, Chen X, Zhuang H, et al: An integrated
analysis of SOCS1 down-regulation in HBV infection-related
hepatocellular carcinoma. J Viral Hepat. 21:264–271. 2014.
View Article : Google Scholar :
|
|
18
|
Gao XD, Qu JH, Chang XJ, Lu YY, Bai WL,
Wang H, Xu ZX, An LJ, Wang CP, Zeng Z, et al: Hypomethylation of
long interspersed nuclear element-1 promoter is associated with
poor outcomes for curative resected hepatocellular carcinoma. Liver
Int. 34:136–146. 2014. View Article : Google Scholar :
|
|
19
|
Villanueva A, Portela A, Sayols S,
Battiston C, Hoshida Y, Méndez-González J, Imbeaud S, Letouzé E,
Hernandez-Gea V, Cornella H, et al HEPTROMIC Consortium: DNA
methylation-based prognosis and epidrivers in hepatocellular
carcinoma. Hepatology. 61:1945–1956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mah WC, Thurnherr T, Chow PK, Chung AY,
Ooi LL, Toh HC, Teh BT, Saunthararajah Y and Lee CG: Methylation
profiles reveal distinct subgroup of hepatocellular carcinoma
patients with poor prognosis. PLoS One. 9:e1041582014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan T, Zhao JJ, Bi XY, Zhao H, Huang Z, Li
ZY, Zhou JG, Li Y, Li C, Cai JQ, et al: Prognosis of hepatocellular
carcinoma: A study of 832 cases. Zhonghua Zhong Liu Za Zhi.
35:54–58. 2013.In Chinese. PubMed/NCBI
|
|
22
|
Tandon P and Garcia-Tsao G: Prognostic
indicators in hepato-cellular carcinoma: a systematic review of 72
studies. Liver Int. 29:502–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu W, Dong J, Huang Z, Guo D, Liu Y and
Shi S: Comparison of four current staging systems for Chinese
patients with hepatocellular carcinoma undergoing curative
resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol.
23:1874–1878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fukushige S and Horii A: DNA methylation
in cancer: A gene silencing mechanism and the clinical potential of
its biomarkers. Tohoku J Exp Med. 229:173–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gan L, Chen S, Zhong J, Wang X, Lam EK,
Liu X, Zhang J, Zhou T, Yu J, Si J, et al: ZIC1 is downregulated
through promoter hypermethylation, and functions as a tumor
suppressor gene in colorectal cancer. PLoS One. 6:e169162011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhong S, Tang MW, Yeo W, Liu C, Lo YM and
Johnson PJ: Silencing of GSTP1 gene by CpG island DNA
hypermethylation in HBV-associated hepatocellular carcinomas. Clin
Cancer Res. 8:1087–1092. 2002.PubMed/NCBI
|
|
27
|
Kaur P, Mani S, Cros MP, Scoazec JY,
Chemin I, Hainaut P and Herceg Z: Epigenetic silencing of sFRP1
activates the canonical Wnt pathway and contributes to increased
cell growth and proliferation in hepatocellular carcinoma. Tumour
Biol. 33:325–336. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He G, Hu S, Zhang D, Wu P, Zhu X, Xin S,
Lu G, Ding Y and Liang L: Hypermethylation of FOXD3 suppresses cell
proliferation, invasion and metastasis in hepatocellular carcinoma.
Exp Mol Pathol. 99:374–382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shin SH, Lee KH, Kim BH, Lee S, Lee HS,
Jang JJ and Kang GH: Downregulation of spleen tyrosine kinase in
hepatocellular carcinoma by promoter CpG island hypermethylation
and its potential role in carcinogenesis. Lab Invest. 94:1396–1405.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu X, Liu RF, Wan BB, Xing WM, Huang J and
Han ZG: Expression of a novel gene FAM43B repressing cell
proliferation is regulated by DNA methylation in hepatocellular
carcinoma cell lines. Mol Cell Biochem. 354:11–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
